We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Analysis of Drug Recalls Puts Spotlight on Bacteria
FDA Analysis of Drug Recalls Puts Spotlight on Bacteria
December 1, 2009
An FDA analysis of recalls shows drugmakers may be ignoring a persistent bacteria cited in a recent recall and warning letter.